Get the Stockscreener App
1.16
3.33%
-0.04
After Hours:
1.16
Elutia Inc stock is traded at $1.16, with a volume of 307.48K.
It is down -3.33% in the last 24 hours and up +0.87% over the past month.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
See More
Previous Close:
$1.20
Open:
$1.19
24h Volume:
307.48K
Relative Volume:
2.29
Market Cap:
$51.28M
Revenue:
$18.89M
Net Income/Loss:
$-20.44M
P/E Ratio:
-1.4726
EPS:
-0.7877
Net Cash Flow:
$-46.69M
1W Performance:
+12.62%
1M Performance:
+0.87%
6M Performance:
+96.58%
1Y Performance:
-31.76%
1-Day Range:
$1.10
$1.28
1-Week Range:
$1.02
$1.28
52-Week Range:
$0.50
$2.64
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia Inc
Sector
Industry
Phone
240-247-1143
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
1.16 | 53.05M | 18.89M | -20.44M | -46.69M | -0.7877 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-02-20 | Initiated | Cowen | Outperform |
| Nov-02-20 | Initiated | Piper Sandler | Overweight |
| Nov-02-20 | Initiated | Truist | Buy |
Elutia Inc Stock (ELUT) Latest News
Elutia Inc. (ELUT) Dips 3.33% as Stock Hovers Near Critical $1.10 SupportRevenue Growth Stocks - Newser
A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching - GlobeNewswire
ELUT Q1 2026 Earnings: EPS Misses Estimates as Stock Moves HigherPro Trader Picks - Newser
Elutia (ELUT) Q1 2026 Earnings Miss by Significant: Key TakeawaysEarnings Season Preview - Newser
Elutia (ELUT) Q1 2026 Results: Profit Pressure, Guidance CutPost-Earnings Reaction - Newser
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - Sahm
ELUT: Antibiotic-eluting matrix targets high breast reconstruction infection rates in a $1.5B market - TradingView
Is Elutia (ELUT) Overvalued After Q1 2026? EPS Not Disclosed; Re - GuruFocus
Elutia (ELUT) Q1 2026 Earnings Transcript - AOL.com
Elutia (NASDAQ: ELUT) posts wider Q1 2026 loss while holding $28.5M cash - Stock Titan
About Us | Oil & Gas JournalElutia, Inc.Class A Common Stock (Nasdaq:ELUT) Stock Quote - FinancialContent
Elutia Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ELUT) 2026-05-15 - Seeking Alpha
Elutia Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Elutia to Present at the 16th Annual LD Micro Invitational on May 18th - Sahm
Elutia Inc (ELUT) Q1 2026 Earnings Call Highlights: Strategic Ad - GuruFocus
Number of shareholders of Elutia, Inc. – NASDAQ:ELUT - TradingView
Transcript : Elutia Inc., Q1 2026 Earnings Call, May 14, 2026 - marketscreener.com
ELUT: Q1 2026 delivered revenue growth, margin gains, and strategic progress toward NXT-41x launch - TradingView
Elutia Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Elutia’s Q1 2026 earnings miss EPS, revenue exceeds forecast - Investing.com
Elutia earnings missed by $0.02, revenue topped estimates - Investing.com Canada
Elutia Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Elutia 1Q Loss $7.47M >ELUT - Moomoo
Elutia reports Q1 results, expects FDA clearance for NXT-41 By Investing.com - Investing.com South Africa
Elutia : Presentation (ELUT Earning Call 14May26 Final) - marketscreener.com
Elutia reports Q1 results, expects FDA clearance for NXT-41 - Investing.com
ELUTIA ($ELUT) Releases Q1 2026 Earnings - Quiver Quantitative
Elutia to detail tech to curb infections after breast cancer reconstruction - Stock Titan
Elutia (NASDAQ: ELUT) Q1 loss deepens while NXT-41 pipeline and margins progress - Stock Titan
Elutia Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Elutia Reports First Quarter 2026 Results and Highlights - GlobeNewswire
Elutia to Present at the 16th Annual LD Micro Invitational May 18th - TMX Newsfile
Elutia (ELUT) Steady at $$1.04 — Awaiting Next Catalyst 2026-05-14Profitability Factor - Newser
TradingKey - TradingKey
ELUTIA INC (ELUT) Eps Diluted (TTM) - Zacks Investment Research
Earnings Preview: Elutia to Report Financial Results Post-market on May 14 - Moomoo
Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - The Manila Times
ELUT Elutia delivers blowout Q4 2025 EPS results, yet shares fall 1.83% in post-earnings trading.PEG Ratio - newser.com
What factors are influencing Elutia (ELUT) stock | Q4 2025: EPS Beats ForecastsStock Market Community - newser.com
Elutia (ELUT) Stock Movers | Q4 2025: EPS Tops ViewsTurnaround Phase - Cổng thông tin điện tử tỉnh Lào Cai
ELUT (Elutia Inc.) posts a profitable Q4 2025 EPS result that far exceeds Wall Street’s consensus loss estimates. - Xã Thanh Hà
Elutia (NASDAQ: ELUT) seeks approval for larger equity plan and board slate - Stock Titan
[ARS] ELUTIA INC. SEC Filing - Stock Titan
Elutia (ELUT) Stock Volume Cluster (Smart Money Exits) 2026-04-20Correlation Analysis - Cổng thông tin điện tử tỉnh Lào Cai
Boston Scientific buys Elutia's bioenvelope business for $88 million - MSN
Elutia (ELUT) director receives 6,250 shares as RSUs vest, holding 125,000 - Stock Titan
Elutia Inc. (NASDAQ:ELUT) Q4 2025 earnings call transcript - MSN
Aug Retail: Is Elutia Inc forming a breakout patternTrend Reversal & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Quarterly Risk: Can Elutia Inc be recession proofWeekly Loss Report & Safe Entry Point Identification - baoquankhu1.vn
ELUT PE Ratio & Valuation, Is ELUT Overvalued - Intellectia AI
Growth Recap: Is Elutia Inc stock risky to hold nowEarnings Beat & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Elutia Inc Stock (ELUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):